PAA4 COST-EFFECTIVENESS ANALYSIS OF OMALIZUMABVS STANDARD THERAPY (ST), IN THE MANAGEMENT OF SEVERE ASHTMA
Abstract
Authors
M Martinez G Vega FM Garcia R Rivas F Fon L Zapata
M Martinez G Vega FM Garcia R Rivas F Fon L Zapata
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now